Xingtai Gene Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Xingtai Gene General Information
Description
Provider of medical analysis services intended to enable early disease detection and health management. The company offers non-invasive prenatal testing, hereditary cancer screening, newborn genetic screening, personal DNA decoding, preimplantation chromosomal screening, and infectious disease analysis, enabling healthcare providers and patients to identify genetic risks and latent diseases for informed health planning.
Contact Information
Corporate Office
- Thailand
Corporate Office
- Thailand
Xingtai Gene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xingtai Gene Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xingtai Gene FAQs
-
When was Xingtai Gene founded?
Xingtai Gene was founded in 2025.
-
Where is Xingtai Gene headquartered?
Xingtai Gene is headquartered in Thailand.
-
What industry is Xingtai Gene in?
Xingtai Gene’s primary industry is Laboratory Services (Healthcare).
-
Is Xingtai Gene a private or public company?
Xingtai Gene is a Private company.
-
What is Xingtai Gene’s current revenue?
The current revenue for Xingtai Gene is .
-
Who are Xingtai Gene’s investors?
BGI Genomics has invested in Xingtai Gene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process